Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Pituitary Neoplasms × pasireotide × Clear all

Phase

Phase 2 4 Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Acromegaly 2 Pancreatic Neoplasms 1 Lymphoma, Follicular 1 Growth Disorders 1 Gigantism 1 Carcinoid Tumor 1

Interventions

pasireotide 2 Cabergoline 2 lanreotide 1 Solutions 1 Radiosurgery 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02354508 2019-12-10

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Novartis

Phase 3 Completed

123 enrolled 27 charts

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01137682 2018-04-05

PAOLA

Novartis

Phase 3 Completed

198 enrolled 17 charts

Acromegaly, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡